Geron Enhances Oncology Expertise to Advance Corporate Objectives

    NEXT STORY
    Genmab Announces Submission of Extension of Marketing Authorization to European Medicines Agency for Subcutaneous Formulation of Daratumumab
    PREV STORY
    Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for Initiation of a Global Phase 2 Trial for TransCon™ CNP in Children with Achondroplasia
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    resTORbio Appoints Jeffrey Chodakewitz, M.D., to its Board of Directors

    Brings extensive experience in clinical and pipeline development to resTORbio’s BoardBOSTON, Aug. 15, 2018 ...

    author_avatar
    NASDAQ Market News

    OPKO Health Enrolls First Patient in Phase 2B Study of OPK88004 to Treat Benign Prostatic Hypertrophy

    MIAMI, Nov. 27, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) (“OPKO” or “the ...

    author_avatar
    NASDAQ Market News

    ABLYNX ANNOUNCES WARRANT EXERCISE

    REGULATED INFORMATION GHENT, Belgium, 17 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] ...

    author_avatar
    NASDAQ Market News